Polymorphism of Pfmdr-1 and Pfk13 in Plasmodium falciparum and Associated Clinical and Biological Characteristics in Patients from Bouaflé, Bondoukou and Séguéla (Côte d’Ivoire)

Introduction: Monitoring molecular markers of Plasmodium falciparum resistance to antimalarial drugs is a major challenge in the global fight against malaria. Aim: This study aimed to determine polymorphisms in the Pfmdr1 and Pfk13 genes and their associations with clinical and biological characteristics among patients from Bouaflé, Bondoukou and Séguéla (Côte d’Ivoire). Methods: This cross-sectional study was conducted from May to November 2019 among patients from the three localities. Only patients with a positive thick blood smear and confirmed P. falciparum monoinfection were included. Polymorphisms in the Pfmdr1 and Pfk13 genes were determined by Sanger sequencing. Associations between mutant profiles and sex, age and parasite density were assessed using Pearson’s chi-squared (χ²) test or Fisher’s exact test (when expected counts were < 5), followed by logistic regression for Pfmdr1 only. Results: The Pfmdr1 mutant profile was observed in 63.0% of isolates (46/73; 95% CI: 50.9–74.0), compared with 11.3% (6/53; 95% CI: 4.3–23.0) for Pfk13. No significant associations were found between the Pfmdr1 mutant profile and age (OR = 1.04; p = 0.184), sex (OR = 0.90; p = 0.845) or parasite density (OR = 1.95; p = 0.131). Median parasite densities did not differ significantly between patients infected with mutant and wild-type parasites for either Pfk13 (4,581 vs. 6,000; p = 0.574) or Pfmdr1 (7,828 vs. 3,000; p = 0.117). Conclusion: This study provides insight into the relationship between Pfmdr1 and Pfk13 polymorphisms in P. falciparum and patients’ clinical and biological characteristics. These findings support continued molecular surveillance of these two markers.

Authors

Institutions

Publication Details

Journal
Biotechnology Journal International
Published
2026-11-19
DOI
https://doi.org/10.9734/bji/2026/v30i6932
Primary Topic
Malaria Research and Control
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Polymorphism of Pfmdr-1 and Pfk13 in Plasmodium falciparum and Associated Clinical and Biological Characteristics in Patients from Bouaflé, Bondoukou and Séguéla (Côte d’Ivoire)

Akpa Paterne Gnagne, Minayégninrin Koné, William Yavo, Aby Jerôme Kouakou et al.
Biotechnology Journal International
Malaria Research and Control
article

Polymorphism of Pfmdr-1 and Pfk13 in Plasmodium falciparum and Associated Clinical and Biological Characteristics in Patients from Bouaflé, Bondoukou and Séguéla (Côte d’Ivoire)

Akpa Paterne Gnagne, Minayégninrin Koné, William Yavo, Aby Jerôme Kouakou, Kouakou Brice Bla, Wèyème Carole Zita Gohoun, Akoua Valérie BEDIA, Habibatou KONATÉ-TOURÉ, Missa Firmin KOUASSI, Mahama TOURE
article en

Abstract

Introduction: Monitoring molecular markers of Plasmodium falciparum resistance to antimalarial drugs is a major challenge in the global fight against malaria. Aim: This study aimed to determine polymorphisms in the Pfmdr1 and Pfk13 genes and their associations with clinical and biological characteristics among patients from Bouaflé, Bondoukou and Séguéla (Côte d’Ivoire). Methods: This cross-sectional study was conducted from May to November 2019 among patients from the three localities. Only patients with a positive thick blood smear and confirmed P. falciparum monoinfection were included. Polymorphisms in the Pfmdr1 and Pfk13 genes were determined by Sanger sequencing. Associations between mutant profiles and sex, age and parasite density were assessed using Pearson’s chi-squared (χ²) test or Fisher’s exact test (when expected counts were < 5), followed by logistic regression for Pfmdr1 only. Results: The Pfmdr1 mutant profile was observed in 63.0% of isolates (46/73; 95% CI: 50.9–74.0), compared with 11.3% (6/53; 95% CI: 4.3–23.0) for Pfk13. No significant associations were found between the Pfmdr1 mutant profile and age (OR = 1.04; p = 0.184), sex (OR = 0.90; p = 0.845) or parasite density (OR = 1.95; p = 0.131). Median parasite densities did not differ significantly between patients infected with mutant and wild-type parasites for either Pfk13 (4,581 vs. 6,000; p = 0.574) or Pfmdr1 (7,828 vs. 3,000; p = 0.117). Conclusion: This study provides insight into the relationship between Pfmdr1 and Pfk13 polymorphisms in P. falciparum and patients’ clinical and biological characteristics. These findings support continued molecular surveillance of these two markers.

Biotechnology Journal InternationalVol. 30(6)
Université Alassane Ouattara (CI), Université Félix Houphouët-Boigny (CI)
Malaria Research and Control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon